Literature DB >> 2187601

Inhibition of p34cdc2 kinase activity by etoposide or irradiation as a mechanism of G2 arrest in Chinese hamster ovary cells.

R B Lock1, W E Ross.   

Abstract

The mammalian homologue of the yeast cdc2 gene product, p34cdc2, is a cell cycle-regulated protein essential for mitosis. We have used polyclonal antisera raised against a peptide corresponding to the carboxyl terminus of the sequence of human cdc2 to study p34cdc2 in Chinese hamster ovary (CHO) cells. Major bands are immunoprecipitated at a molecular weight of 34,000, although not in the presence of competing antigenic peptide. p34cdc2 is coimmunoprecipitated with proteins of molecular weights of 52,000 and 57,000. Immunoprecipitates express histone H1 kinase activity which varies throughout the cell cycle, maximal activity being observed in G2-M. The activity of the p34cdc2 kinase varies according to its association with the Mr 52,000 and 57,000 proteins and according to their phosphorylation state. Treatment of either asynchronous CHO cells or an enriched G2 population with the antitumor agent, etoposide, results in rapid inhibition of immunoprecipitated p34cdc2 kinase activity, which is not due to a direct effect of drug upon the enzyme. p34cdc2 kinase activity recovers as cells arrest in G2 and a second etoposide treatment further inhibits p34cdc2 kinase activity and prolongs G2 arrest. Exposure of asynchronous CHO cells to gamma-irradiation also inhibits p34cdc2 kinase activity within 1 h. Again this activity recovers as cells accumulate in G2. These results suggest that DNA damage in CHO cells elicits a response which results in inhibition of p34cdc2 kinase activity and, consequently, G2 arrest.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2187601

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  37 in total

1.  Influence of the G2 cell cycle block abrogator pentoxifylline on the expression and subcellular location of cyclin B1 and p34cdc2 in HeLa cervical carcinoma cells.

Authors:  T Theron; L Böhm
Journal:  Cell Prolif       Date:  2000-02       Impact factor: 6.831

Review 2.  Control of the G2/M transition.

Authors:  George R Stark; William R Taylor
Journal:  Mol Biotechnol       Date:  2006-03       Impact factor: 2.695

Review 3.  Apoptosis induced by anticancer drugs.

Authors:  J A Hickman
Journal:  Cancer Metastasis Rev       Date:  1992-09       Impact factor: 9.264

4.  Different effects of p58PITSLRE on the apoptosis induced by etoposide, cycloheximide and serum-withdrawal in human hepatocarcinoma cells.

Authors:  Ming M Cai; Song W Zhang; Si Zhang; She Chen; Jun Yan; Xiao Y Zhu; Yun Hu; Chun Chen; Jian X Gu
Journal:  Mol Cell Biochem       Date:  2002-09       Impact factor: 3.396

5.  Effects of cardiotoxin III on expression of genes and proteins related to G2/M arrest and apoptosis in K562 cells.

Authors:  Sheng-Huei Yang; Chien-Hsun Tsai; Mei-Chin Lu; Yung-Ning Yang; Ching-Ming Chien; Sheng-Fung Lin; Shinne-Ren Lin
Journal:  Mol Cell Biochem       Date:  2006-12-06       Impact factor: 3.396

6.  Inhibition of replicon initiation in human cells following stabilization of topoisomerase-DNA cleavable complexes.

Authors:  W K Kaufmann; J C Boyer; L L Estabrooks; S J Wilson
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

7.  Inhibitors of DNA topoisomerase II prevent chromatid separation in mammalian cells but do not prevent exit from mitosis.

Authors:  C S Downes; A M Mullinger; R T Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

8.  The role of inhibitory phosphorylation of CDC2 following DNA replication block and radiation-induced damage in human cells.

Authors:  A Blasina; E S Paegle; C H McGowan
Journal:  Mol Biol Cell       Date:  1997-06       Impact factor: 4.138

9.  Persistent DNA damage inhibits S-phase and G2 progression, and results in apoptosis.

Authors:  D K Orren; L N Petersen; V A Bohr
Journal:  Mol Biol Cell       Date:  1997-06       Impact factor: 4.138

10.  A mitotic topoisomerase II checkpoint in budding yeast is required for genome stability but acts independently of Pds1/securin.

Authors:  Catherine A Andrews; Amit C Vas; Brian Meier; Juan F Giménez-Abián; Laura A Díaz-Martínez; Julie Green; Stacy L Erickson; Kristyn E Vanderwaal; Wei-Shan Hsu; Duncan J Clarke
Journal:  Genes Dev       Date:  2006-05-01       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.